ATE520656T1 - Verfahren zur herstellung von 2-oxo-1- pyrrolidinderivaten - Google Patents
Verfahren zur herstellung von 2-oxo-1- pyrrolidinderivatenInfo
- Publication number
- ATE520656T1 ATE520656T1 AT06026414T AT06026414T ATE520656T1 AT E520656 T1 ATE520656 T1 AT E520656T1 AT 06026414 T AT06026414 T AT 06026414T AT 06026414 T AT06026414 T AT 06026414T AT E520656 T1 ATE520656 T1 AT E520656T1
- Authority
- AT
- Austria
- Prior art keywords
- oxo
- producing
- pyrrolidine derivatives
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75407005P | 2005-12-21 | 2005-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE520656T1 true ATE520656T1 (de) | 2011-09-15 |
Family
ID=37963913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06026414T ATE520656T1 (de) | 2005-12-21 | 2006-12-20 | Verfahren zur herstellung von 2-oxo-1- pyrrolidinderivaten |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8338621B2 (de) |
| EP (1) | EP1806339B1 (de) |
| AT (1) | ATE520656T1 (de) |
| ES (1) | ES2371351T3 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5100298B2 (ja) * | 2007-10-11 | 2012-12-19 | 株式会社トクヤマ | 光学活性α−スルホニルオキシカルボン酸アミド誘導体及びその製造方法 |
| ES2465478T3 (es) * | 2008-05-30 | 2014-06-05 | Ucb Pharma, S.A. | Composiciones farmacéuticas que comprenden brivaracetam |
| US8722715B2 (en) * | 2008-11-07 | 2014-05-13 | NovaBay Pharmaceuticals | Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| TW201124078A (en) | 2009-12-22 | 2011-07-16 | Du Pont | Fungicidal 2-(bicyclic aryloxy) carboxamides |
| US8697879B2 (en) | 2010-07-01 | 2014-04-15 | Northwestern University | Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitors |
| WO2012087372A1 (en) | 2010-12-22 | 2012-06-28 | E. I. Du Pont De Nemours And Company | Fungicidal 2-(bicyclic aryloxy)carboxamides |
| SG11201407309XA (en) * | 2012-05-08 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of epilepsy |
| CN106349142A (zh) * | 2013-06-19 | 2017-01-25 | 成都百途医药科技有限公司 | 一种奥拉西坦的合成方法 |
| ES2860298T3 (es) | 2014-01-21 | 2021-10-04 | Janssen Pharmaceutica Nv | Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso |
| DK3431106T3 (da) | 2014-01-21 | 2021-03-15 | Janssen Pharmaceutica Nv | Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse |
| WO2016075082A1 (en) | 2014-11-10 | 2016-05-19 | Sandoz Ag | Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam |
| CN104892483B (zh) * | 2015-04-16 | 2017-05-24 | 广东赛烽医药科技有限公司 | 2‑氧代‑1‑吡咯烷手性衍生物的制备方法 |
| CN108689968B (zh) * | 2015-05-25 | 2020-09-15 | 苏州鹏旭医药科技有限公司 | 两种化合物及其制备方法和在合成布瓦西坦中的用途 |
| JP6872500B2 (ja) * | 2015-05-25 | 2021-05-19 | エステベ・キミカ・ソシエダッド・アノニマＥｓｔｅｖｅ Ｑｕｉｍｉｃａ， Ｓ．Ａ． | ブリバラセタムを製造する方法 |
| CN108101823A (zh) | 2018-02-13 | 2018-06-01 | 扬州奥锐特药业有限公司 | 一种高手性纯度内酰胺中间体及布瓦西坦的制备方法 |
| WO2020051796A1 (zh) * | 2018-09-12 | 2020-03-19 | 上海宣泰医药科技有限公司 | 布瓦西坦的制备方法及其中间体 |
| CN111333563B (zh) * | 2018-12-19 | 2023-11-07 | 上海科胜药物研发有限公司 | 一种布瓦西坦中间体的制备方法 |
| US10781170B1 (en) | 2019-10-21 | 2020-09-22 | Divi's Laboratories Ltd. | Process for preparing Brivaracetam |
| CN111675643B (zh) * | 2020-06-15 | 2021-10-26 | 浙江天宇药业股份有限公司 | 一种布瓦西坦的制备方法 |
| US11400074B1 (en) | 2021-02-01 | 2022-08-02 | Divi's Laboratories Ltd. | Enzymatic process for the preparation of (2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butyric acid and its conversion into brivaracetam |
| WO2023100110A1 (en) * | 2021-12-02 | 2023-06-08 | Macfarlan Smith Limited | Process for preparing brivaracetam |
| CN114409586A (zh) * | 2021-12-23 | 2022-04-29 | 山东诚汇双达药业有限公司 | 一种左乙拉西坦的制备方法 |
| US11884623B2 (en) | 2022-05-23 | 2024-01-30 | Divi's Laboratories Ltd. | Process for the preparation of (R)-4-propyl pyrrolidine-2-one, a key intermediate for synthesis of brivaracetam |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB8827389D0 (en) | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| ATE410412T1 (de) * | 2001-08-10 | 2008-10-15 | Ucb Pharma Sa | Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen |
| US7612215B2 (en) | 2004-06-11 | 2009-11-03 | Ucb Pharma, S.A. | Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation |
-
2006
- 2006-12-19 US US11/612,654 patent/US8338621B2/en not_active Expired - Fee Related
- 2006-12-20 EP EP06026414A patent/EP1806339B1/de active Active
- 2006-12-20 ES ES06026414T patent/ES2371351T3/es active Active
- 2006-12-20 AT AT06026414T patent/ATE520656T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1806339B1 (de) | 2011-08-17 |
| EP1806339A1 (de) | 2007-07-11 |
| US8338621B2 (en) | 2012-12-25 |
| US20080009638A1 (en) | 2008-01-10 |
| ES2371351T3 (es) | 2011-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE520656T1 (de) | Verfahren zur herstellung von 2-oxo-1- pyrrolidinderivaten | |
| DE602005026987D1 (de) | Verfahren zur herstellung von 1,2-dichlorethan | |
| DE602006012274D1 (de) | Verfahren und Vorrichtung zur Herstellung von Gruppe III Nitridkristall. | |
| DE60325188D1 (de) | Verfahren zur herstellung von sterilen, stabilisierten nanodispersionen | |
| DK1757276T3 (da) | Fremgangsmåde til fremstilling af nano- og mikrokapsler af edderkoppesilkeprotein | |
| ATE413875T1 (de) | Zusammensetzungen enthaltend levetiracetam und verfahren zu deren herstellung. | |
| ATE482966T1 (de) | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide | |
| DE602007007666D1 (de) | Verfahren zur herstellung von nebivolol | |
| DE502005001841D1 (de) | Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten | |
| ATE548353T1 (de) | Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon. | |
| DE502005000428D1 (de) | Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen | |
| DE602005003472D1 (de) | Verfahren zur herstellung von 2-oxo-1-pyrrolidinderivaten durch intramolekulare allylierung | |
| DE502005007702D1 (de) | Verfahren zur herstellung von terrylen-3,4:11,12-t | |
| DE60042035D1 (de) | Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen | |
| DE602005014280D1 (de) | Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten | |
| ATE445601T1 (de) | Verfahren zur herstellung von carvedilol und seinen enantiomeren | |
| ATE455778T1 (de) | Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat | |
| DE602005000377D1 (de) | Verfahren zur herstellung von n-alkyl-pyrrolidonen | |
| DE60210778D1 (de) | Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| ATE464289T1 (de) | Neues verfahren zur herstellung von thoc | |
| ATE521680T1 (de) | Sauerstoffabfangmittel und verfahren zu seiner herstellung | |
| ATE368661T1 (de) | Verfahren zur herstellung von 5-(4-fluorphenyl)-1- 2-((2r,4r)-4-hydroxy-6-oxo etrahydropyran-2- yl)ethylö-2-isopropyl-4-phenyl-1h-pyrrol-3- carbonsäurephenylamid | |
| DE602004001646D1 (de) | Verfahren zur Herstellung von Pyran | |
| DE602004002692D1 (de) | Verfahren zur Herstellung von Topiramate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |